136 related articles for article (PubMed ID: 17298198)
1. [Voriconazole-associated phototoxicity].
Serra Soler G; Delgado Sánchez O; Esteban Marcos E; Martínez-López I; Femenías Sureda M
Farm Hosp; 2006; 30(6):386-7. PubMed ID: 17298198
[No Abstract] [Full Text] [Related]
2. Voriconazole-associated phototoxicity.
Riahi RR; Cohen PR
Dermatol Online J; 2011 Feb; 17(2):15. PubMed ID: 21382298
[TBL] [Abstract][Full Text] [Related]
3. [Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
Isobe K; Muraoka S; Sugino K; Yamazaki Y; Kikuchi N; Hamanaka N; Takai Y; Shimizu K; Kimura K; Hiroi N; Shibuya K; Homma S
Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):489-93. PubMed ID: 17644946
[TBL] [Abstract][Full Text] [Related]
4. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Denning DW; Griffiths CE
Clin Exp Dermatol; 2001 Nov; 26(8):648-53. PubMed ID: 11722447
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
Kobayashi K; Kami M; Murashige N; Kishi Y; Fujisaki G; Mitamura T
Haematologica; 2004 Nov; 89(11):ECR42. PubMed ID: 15533847
[No Abstract] [Full Text] [Related]
6. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
Chow L; Brown NE; Kunimoto D
Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856
[TBL] [Abstract][Full Text] [Related]
8. Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
Vandecasteele SJ; Van Wijngaerden E; Peetermans WE
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):656-7. PubMed ID: 15248093
[No Abstract] [Full Text] [Related]
9. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
Patel AR; Turner ML; Baird K; Gea-Banacloche J; Mitchell S; Pavletic SZ; Wise B; Cowen EW
Biol Blood Marrow Transplant; 2009 Mar; 15(3):370-6. PubMed ID: 19203729
[TBL] [Abstract][Full Text] [Related]
10. Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
Curigliano G; Formica V; De Pas T; Spitaleri G; Pietri E; Fazio N; de Braud F; Goldhirsch A
Ann Oncol; 2006 Jul; 17(7):1174-5. PubMed ID: 16410362
[No Abstract] [Full Text] [Related]
11. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
Kohno S; Ogawa K; Kurashima A; Niki Y; Maesaki S
Jpn J Antibiot; 2007 Dec; 60(6):321-34. PubMed ID: 18447204
[No Abstract] [Full Text] [Related]
13. Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
de Sévaux RG; Kullberg BJ; Verweij PE; van de Nes JA; Meis JF; van der Meer JW
Clin Infect Dis; 1998 Apr; 26(4):996-7. PubMed ID: 9564492
[No Abstract] [Full Text] [Related]
14. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
15. Adverse reactions to voriconazole.
Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
[TBL] [Abstract][Full Text] [Related]
16. Lack of cross-hepatotoxicity between voriconazole and posaconazole.
Foo H; Gottlieb T
Clin Infect Dis; 2007 Sep; 45(6):803-5. PubMed ID: 17712772
[No Abstract] [Full Text] [Related]
17. The safety of voriconazole.
Potoski BA; Brown J
Clin Infect Dis; 2002 Nov; 35(10):1273-5. PubMed ID: 12410490
[No Abstract] [Full Text] [Related]
18. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
Jain LR; Denning DW
J Infect; 2006 May; 52(5):e133-7. PubMed ID: 16427702
[TBL] [Abstract][Full Text] [Related]
19. Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
González Rozas M; Alvarez Tundidor S; Pineda Alonso M
Nefrologia; 2011; 31(1):112-3. PubMed ID: 21270925
[No Abstract] [Full Text] [Related]
20. Voriconazole therapy in children with cystic fibrosis.
Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
